A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus
Melanie Thompson, Michael Saag, Edwin Dejesus, Joseph Gathe, Jay Lalezari, Alan L. Landay, Jerry Cade, Jeffrey Enejosa, Eric Lefebvre, Judith Feinberg
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus'. Together they form a unique fingerprint.